Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients

An analysis of national representative claims database

Meng Tse Gabriel Lee, Shih Hao Lee, Shy Shin Chang, Si Huei Lee, Matthew Lee, Cheng Chung Fang, Shyr Chyr Chen, Chien Chang Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

There are very limited data on the postmarketing outcome comparison of different guideline antibiotic regimens for patients with urinary tract infections (UTIs).We carried out a population-based comparative effectiveness study from year 2000 through 2009, using the administrative data of 2 million patients from the National Health Informatics Project of Taiwan. Treatment failure was defined as either hospitalization or emergency department visits for UTI. Odd ratios were computed using conditional logistic regression models matched on propensity score.We identified 73,675 individuals with UTI, of whom 54,796 (74.4%) received trimethoprim-sulfamethoxazole (TMP-SMX), 4184 (5.7%) received ciprofloxacin, 3142 (4.3%) received levofloxacin, 5984 (8.1%) received ofloxacin, and 5569 (7.6%) received norfloxacin. Compared with TMP-SMX, the composite treatment failure was significantly lowered for norfloxacin in propensity score (PS) matching analyses (OR, 0.73; 95% CI, 0.54-0.99). Both norfloxacin (PS-matched OR, 0.68; 95% CI, 0.47-0.98) and ofloxacin (PS-matched OR, 0.70; 95% CI, 0.49-0.99) had significantly lowered composite treatment failure rate when compared with ciprofloxacin. Subgroup analysis suggested that both norfloxacin and ofloxacin were more effective in female patients without complications (W/O indwelling catheters, W/O bedridden status and W/O spinal cord injury), when compared with either TMP-SMX or ciprofloxacin.Among outpatients receiving oral fluoroquinolone therapy for UTIs, there was evidence of superiority of norfloxacin or ofloxacin over ciprofloxacin or TMP-SMX in terms of treatment failure. Given the observational nature of this study and regional difference in antibiotic resistance patterns, more studies are required to validate our results.

Original languageEnglish
Pages (from-to)e304
JournalMedicine (United States)
Volume93
Issue number28
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Fingerprint

Norfloxacin
Propensity Score
Urinary Tract Infections
Ofloxacin
Sulfamethoxazole Drug Combination Trimethoprim
Ciprofloxacin
Treatment Failure
Outpatients
Databases
Anti-Bacterial Agents
Logistic Models
Therapeutics
Levofloxacin
Informatics
Indwelling Catheters
Fluoroquinolones
Microbial Drug Resistance
Spinal Cord Injuries
Taiwan
Observational Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients : An analysis of national representative claims database. / Lee, Meng Tse Gabriel; Lee, Shih Hao; Chang, Shy Shin; Lee, Si Huei; Lee, Matthew; Fang, Cheng Chung; Chen, Shyr Chyr; Lee, Chien Chang.

In: Medicine (United States), Vol. 93, No. 28, 01.01.2014, p. e304.

Research output: Contribution to journalArticle

Lee, Meng Tse Gabriel ; Lee, Shih Hao ; Chang, Shy Shin ; Lee, Si Huei ; Lee, Matthew ; Fang, Cheng Chung ; Chen, Shyr Chyr ; Lee, Chien Chang. / Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients : An analysis of national representative claims database. In: Medicine (United States). 2014 ; Vol. 93, No. 28. pp. e304.
@article{36b6656070d44b88a40ea140f123e45a,
title = "Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients: An analysis of national representative claims database",
abstract = "There are very limited data on the postmarketing outcome comparison of different guideline antibiotic regimens for patients with urinary tract infections (UTIs).We carried out a population-based comparative effectiveness study from year 2000 through 2009, using the administrative data of 2 million patients from the National Health Informatics Project of Taiwan. Treatment failure was defined as either hospitalization or emergency department visits for UTI. Odd ratios were computed using conditional logistic regression models matched on propensity score.We identified 73,675 individuals with UTI, of whom 54,796 (74.4{\%}) received trimethoprim-sulfamethoxazole (TMP-SMX), 4184 (5.7{\%}) received ciprofloxacin, 3142 (4.3{\%}) received levofloxacin, 5984 (8.1{\%}) received ofloxacin, and 5569 (7.6{\%}) received norfloxacin. Compared with TMP-SMX, the composite treatment failure was significantly lowered for norfloxacin in propensity score (PS) matching analyses (OR, 0.73; 95{\%} CI, 0.54-0.99). Both norfloxacin (PS-matched OR, 0.68; 95{\%} CI, 0.47-0.98) and ofloxacin (PS-matched OR, 0.70; 95{\%} CI, 0.49-0.99) had significantly lowered composite treatment failure rate when compared with ciprofloxacin. Subgroup analysis suggested that both norfloxacin and ofloxacin were more effective in female patients without complications (W/O indwelling catheters, W/O bedridden status and W/O spinal cord injury), when compared with either TMP-SMX or ciprofloxacin.Among outpatients receiving oral fluoroquinolone therapy for UTIs, there was evidence of superiority of norfloxacin or ofloxacin over ciprofloxacin or TMP-SMX in terms of treatment failure. Given the observational nature of this study and regional difference in antibiotic resistance patterns, more studies are required to validate our results.",
author = "Lee, {Meng Tse Gabriel} and Lee, {Shih Hao} and Chang, {Shy Shin} and Lee, {Si Huei} and Matthew Lee and Fang, {Cheng Chung} and Chen, {Shyr Chyr} and Lee, {Chien Chang}",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/MD.0000000000000304",
language = "English",
volume = "93",
pages = "e304",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "28",

}

TY - JOUR

T1 - Comparative effectiveness of different oral antibiotics regimens for treatment of urinary tract infection in outpatients

T2 - An analysis of national representative claims database

AU - Lee, Meng Tse Gabriel

AU - Lee, Shih Hao

AU - Chang, Shy Shin

AU - Lee, Si Huei

AU - Lee, Matthew

AU - Fang, Cheng Chung

AU - Chen, Shyr Chyr

AU - Lee, Chien Chang

PY - 2014/1/1

Y1 - 2014/1/1

N2 - There are very limited data on the postmarketing outcome comparison of different guideline antibiotic regimens for patients with urinary tract infections (UTIs).We carried out a population-based comparative effectiveness study from year 2000 through 2009, using the administrative data of 2 million patients from the National Health Informatics Project of Taiwan. Treatment failure was defined as either hospitalization or emergency department visits for UTI. Odd ratios were computed using conditional logistic regression models matched on propensity score.We identified 73,675 individuals with UTI, of whom 54,796 (74.4%) received trimethoprim-sulfamethoxazole (TMP-SMX), 4184 (5.7%) received ciprofloxacin, 3142 (4.3%) received levofloxacin, 5984 (8.1%) received ofloxacin, and 5569 (7.6%) received norfloxacin. Compared with TMP-SMX, the composite treatment failure was significantly lowered for norfloxacin in propensity score (PS) matching analyses (OR, 0.73; 95% CI, 0.54-0.99). Both norfloxacin (PS-matched OR, 0.68; 95% CI, 0.47-0.98) and ofloxacin (PS-matched OR, 0.70; 95% CI, 0.49-0.99) had significantly lowered composite treatment failure rate when compared with ciprofloxacin. Subgroup analysis suggested that both norfloxacin and ofloxacin were more effective in female patients without complications (W/O indwelling catheters, W/O bedridden status and W/O spinal cord injury), when compared with either TMP-SMX or ciprofloxacin.Among outpatients receiving oral fluoroquinolone therapy for UTIs, there was evidence of superiority of norfloxacin or ofloxacin over ciprofloxacin or TMP-SMX in terms of treatment failure. Given the observational nature of this study and regional difference in antibiotic resistance patterns, more studies are required to validate our results.

AB - There are very limited data on the postmarketing outcome comparison of different guideline antibiotic regimens for patients with urinary tract infections (UTIs).We carried out a population-based comparative effectiveness study from year 2000 through 2009, using the administrative data of 2 million patients from the National Health Informatics Project of Taiwan. Treatment failure was defined as either hospitalization or emergency department visits for UTI. Odd ratios were computed using conditional logistic regression models matched on propensity score.We identified 73,675 individuals with UTI, of whom 54,796 (74.4%) received trimethoprim-sulfamethoxazole (TMP-SMX), 4184 (5.7%) received ciprofloxacin, 3142 (4.3%) received levofloxacin, 5984 (8.1%) received ofloxacin, and 5569 (7.6%) received norfloxacin. Compared with TMP-SMX, the composite treatment failure was significantly lowered for norfloxacin in propensity score (PS) matching analyses (OR, 0.73; 95% CI, 0.54-0.99). Both norfloxacin (PS-matched OR, 0.68; 95% CI, 0.47-0.98) and ofloxacin (PS-matched OR, 0.70; 95% CI, 0.49-0.99) had significantly lowered composite treatment failure rate when compared with ciprofloxacin. Subgroup analysis suggested that both norfloxacin and ofloxacin were more effective in female patients without complications (W/O indwelling catheters, W/O bedridden status and W/O spinal cord injury), when compared with either TMP-SMX or ciprofloxacin.Among outpatients receiving oral fluoroquinolone therapy for UTIs, there was evidence of superiority of norfloxacin or ofloxacin over ciprofloxacin or TMP-SMX in terms of treatment failure. Given the observational nature of this study and regional difference in antibiotic resistance patterns, more studies are required to validate our results.

UR - http://www.scopus.com/inward/record.url?scp=84920113832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920113832&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000000304

DO - 10.1097/MD.0000000000000304

M3 - Article

VL - 93

SP - e304

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 28

ER -